Vaccination Against Breast Cancer — Studies in an Animal Model

  • Nechama I. Smorodinsky
  • Ronit Yarden
  • Lior Carmon
  • Daniel H. Wreschner
  • Iafa Keydar
  • Mara Hareuveni
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 353)


One of the main mortality causes around the world are malignant diseases. In spite of the development of new cytotoxic drugs and new therapeutic protocols the death rate is still high due to failure of the response to treatment in metastatic cases1. Numerous factors set one tumor apart from another. Tumor specific markers are invaluable for diagnostic, prognostic and therapeutic purposes and enable the clinician to decide on treatment regimes.


T47D Cell Tumor Challenge Internal Image Mouse Mammary Cell Tandem Repeat Array 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    I.C. Henderson, J.C. Harris, D.W. Kinne and S. Hellman. in: “Cancer Principles and Practice of Oncology,” V.I. De Vita, S. Hellman and S.A. Rozenberg, eds., Lippincott Co., Philadelphia (1989).Google Scholar
  2. 2.
    K.E. Hellstrom and I. Hellstrom. in: “Monoclonal Antibodies for Tumor Detection and Drug Targeting,” R.W. Baldwin and U.S. Byers, eds., Academic Press, London (1985).Google Scholar
  3. 3.
    K.D. Bageshow. Br. J. Cancer 48: 167 (1983).CrossRefGoogle Scholar
  4. 4.
    I. Keydar, C.S. Chou, M. Hareuveni, I. Tsarfaty, E. Sahar, G. Selzer, S. Chaitchik and A. Hizi. Proc. Natl. Acad. Sci. USA, 86: 1362 (1989).PubMedCrossRefGoogle Scholar
  5. 5.
    I. Tsarfaty, S. Chaitchik, M. Hareuveni, J. Horev, A. Hizi, D.H. Wreschner and I. Keydar. in: “Breast Cancer Immunodiagnosis and Immunotherapy,” R.L. Ceriani, ed., Plenum, New York (1989).Google Scholar
  6. 6.
    M. Hareuveni, D.H. Wreschner, M.P. Kieny, K. Dott, C. Gautier, C. Tomasetto, I. Keydar, P. Chambon and R. Lathe. Vaccine 9: 618 (1991).PubMedCrossRefGoogle Scholar
  7. 7.
    D.M. Swallow, S. Gendler, B. Griffiths, G. Cornay, J. Taylor-Papadmitriou and M. Bramwell. Nature 328: 82 (1987).PubMedCrossRefGoogle Scholar
  8. 8.
    J. Siddiqui, M. Abe, D. Hayes, E. Shani, E. Yunis and D. Kufe. Proc. Natl. Acad. Sci. USA 85: 2320 (1988).PubMedCrossRefGoogle Scholar
  9. 9.
    M. Hareuveni, I. Tsarfaty, J. Zaretsky, P. Kotkes, J. Horev, S. Zrihan et al. Eur. J. Biochem. 189: 475 (1990).PubMedCrossRefGoogle Scholar
  10. 10.
    D.H. Wreschner, M. Hareuveni, I. Tsarfaty, I. Smorodinsky, J. Horev, J. Zaretsky et al. Eur. J. Biochem. 18: 463 (1990).CrossRefGoogle Scholar
  11. 11.
    D.L. Barnd, M. Lan, R. Metzgar and O.I. Finn. Proc. Natl. Acad. Sci. USA 86: 7159 (1989).PubMedCrossRefGoogle Scholar
  12. 12.
    K.J. Jerome, D.L. Barnd, CM. Boyer, J. Taylor-Papadimitriou, I.F.C. McKenzie, R.C. Bast Jr. and O.J. Finn. in: “Cellular Immunity and the Immunotherapy of Cancer,” UCLA Symposia on Molecular and Cellular Biology, New Series, M.T. Lotze and O.J. Finn, eds., Wiley-Liss (1990).Google Scholar
  13. 13.
    D.L. Sacks, K.M. Esser and A. Sher. J. Exp. Med. 155: 1108 (1982).PubMedCrossRefGoogle Scholar
  14. 14.
    K.E. Stein and T. Soderstrom. J. Exp. Med. 160: 1001 (1984).PubMedCrossRefGoogle Scholar
  15. 15.
    R.C. Kennedy and G.R. Dreesman. J. Exp. Med. 159: 655 (1984).PubMedCrossRefGoogle Scholar
  16. 16.
    D. Herlyn, A.H. Ross and H. Koprowski. Science 232: 100 (1986).PubMedCrossRefGoogle Scholar
  17. 17.
    S. Raychaudhuri, Y. Saeki, H. Fuji and H. Kohler. J. Immunology 137: 1743 (1986).Google Scholar
  18. 18.
    V.K. Lee, T.G. Harriott, V.J. Kuchroo, W.J. Halliday, I. Hellstrom and K.E. Hellstrom. Proc. Natl. Acad. Sci. USA 82: 6286 (1985).PubMedCrossRefGoogle Scholar
  19. 19.
    D. Herlyn, A.H. Ross, D. Hiopoulos and H. Koprowski. Eur. J. Immunol. 17: 1649 (1987).PubMedCrossRefGoogle Scholar
  20. 20.
    E. DeFreitas, H. Suzuki, D. Herlyn, M. Lubeck, H. Sears, M. Herlyn and H. Koprowski. Curr. Top. Microb. Immunol. 119: 75 (1985).CrossRefGoogle Scholar
  21. 21.
    D. Herlyn, M. Lubeck, H.F. Sears and H. Koprowski. J. Immunol. Meth. 85: 27 (1985).CrossRefGoogle Scholar
  22. 22.
    R.A. Robins, G.W.L. Denton, J.D. Hardcastle, E.B. Austin, R.W. Baldwin and L.G. Durrani. Cancer Res. 51: 5425 (1991).PubMedGoogle Scholar
  23. 23.
    N.I. Smorodinsky, Y. Gendler, R. Bakimer, S. Chaitchik, I. Keydar and Y. Shoenfeld. Eur. J. Immunol. 18: 1713 (1988).PubMedCrossRefGoogle Scholar
  24. 24.
    M. Hareuveni, C. Gautier, M.P. Kieny, D.H. Wreschner, P. Chambon and R. Lathe. Proc. Natl. Acad. Sci. USA 87: 9498 (1990).PubMedCrossRefGoogle Scholar
  25. 25.
    C. Gautier, M. Mehtali and R. Lathe. Nucleic Acids Res. 17: 8389 (1989).PubMedCrossRefGoogle Scholar
  26. 26.
    M. Wigler, A. Pellicer, S. Silverstein and R. Axel. Cell 14: 725 (1978).PubMedCrossRefGoogle Scholar
  27. 27.
    R. Sharon and D. Naor. Cancer Immunol. Immunother. 18: 203 (1984).PubMedCrossRefGoogle Scholar
  28. 28.
    H.C. Hoover, M.G. Surdyke, R.B. Dangel, L.C. Peters and M.G. Hanna. Cancer 15: 1236 (1985).CrossRefGoogle Scholar
  29. 29.
    M.K. Wallack, K. McNally, M. Michaelides, J. Basch, A. Bartolucci, H. Siegler, C. Balch and H. Wanebo. Am. Surg. 52: 148 (1986).PubMedGoogle Scholar
  30. 30.
    T. Dalianis. Adv. Cancer Res. 55: 57 (1990).PubMedCrossRefGoogle Scholar
  31. 31.
    D. Talarico, M. Ittmann, A. Balsari, P. Delli-Bovi, R.S. Basch and C. Basilico. Proc. Natl. Acad. Sci. USA 87: 4222 (1990).PubMedCrossRefGoogle Scholar
  32. 32.
    M.C. Wallack, K.R. McNally, E. Leftheriotis, H. Siegler, C. Balch, H. Wanebo, A.A. Bartolucci and J.A. Basch. Cancer 57: 649 (1986).PubMedCrossRefGoogle Scholar
  33. 33.
    N.K. Jerne, Ann. Immunol. 125C: 373 (1974).Google Scholar
  34. 34.
    A. Nisonoff and E. Lamoyi. Clin. Immunol. Immunopathol. 21: 397 (1981).PubMedCrossRefGoogle Scholar
  35. 35.
    H. Kohler, S. Muller and C. Bona. Proc. Soc. Exp. Biol. Med. 178: 189 (1985).PubMedGoogle Scholar
  36. 36.
    H. Kohler. in: “Idiotype in Biology and Medicine,” H. Kohler, J. Urbin and P.A. Cazenave, eds., Academic Press, New York (1985).Google Scholar
  37. 37.
    C. Bona, E. Herber-Katz and W.E. Paul. J. Exp. Med. 153: 951 (1981).PubMedCrossRefGoogle Scholar
  38. 38.
    P.A. Cazenave. Proc. Natl. Acad. Sci. USA 74: 5122 (1977).PubMedCrossRefGoogle Scholar
  39. 39.
    W.R. Thomas, G. Morahan, J.D. Walker and J.F. Miller. J. Exp. Med. 153: 743 (1981).PubMedCrossRefGoogle Scholar
  40. 40.
    M.A. Dichter, H.L. Weiner, B.N. Fields, G. Mitchell, J. Noseworthy, G. Gaulton and M. Greene. Ann. Neurol. 19: 555 (1986).PubMedCrossRefGoogle Scholar
  41. 41.
    R.C. Kennedy, J.W. Eichberg and G.R. Dreesman. Virology 148: 369 (1986).PubMedCrossRefGoogle Scholar
  42. 42.
    M. Bhattacharya-Chatterjee, M.W. Pride, B.K. Seon and H. Kohler. J. Immunol. 139: 1354 (1987).PubMedGoogle Scholar
  43. 43.
    S. Raychaudhuri, Y. Saeki, J.J. Chem, H. Iribe and H. Kohler. J. Immunol. 139: 271 (1987).PubMedGoogle Scholar
  44. 44.
    G.T. Nepom, K.A. Nelson, S.L. Holbeck, I. Hellstrom and K.E. Hellstrom. Proc. Natl. Acad. Sci. USA 81: 2864 (1984).PubMedCrossRefGoogle Scholar
  45. 45.
    M.J. Losman, M. Monestier, H.J. Hansen and D.M. Goldenberg. Int. J. Cancer 46: 310 (1990).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Nechama I. Smorodinsky
    • 1
  • Ronit Yarden
    • 1
  • Lior Carmon
    • 1
  • Daniel H. Wreschner
    • 1
  • Iafa Keydar
    • 1
  • Mara Hareuveni
    • 2
  1. 1.Department of Cell Research and ImmunologyGeorge S. Wise Faculty of Life Sciences Tel Aviv UniversityTel AvivIsrael
  2. 2.Sourasky Medical CenterTel AvivIsrael

Personalised recommendations